G M Yousef
Overview
Explore the profile of G M Yousef including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
1316
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yip S, Christofides A, Banerji S, Downes M, Izevbaye I, Lo B, et al.
Curr Oncol
. 2019 May;
26(2):e241-e254.
PMID: 31043833
Rapid advancements in next-generation sequencing (ngs) technology have created an unprecedented opportunity to decipher the molecular profile of tumours to more effectively prevent, diagnose, and treat cancer. Oncologists now have...
2.
White N, Masui O, Newsted D, Scorilas A, Romaschin A, Bjarnason G, et al.
Br J Cancer
. 2017 Jan;
116(6):e3.
PMID: 28081542
No abstract available.
3.
Saleeb R, Faragalla H, Yousef G, Stewart R, Streutker C
Urol Ann
. 2016 May;
8(2):163-7.
PMID: 27141185
Introduction: Previous publications have shown an increased incidence of various malignancies amongst renal transplant populations. The objective of this study was to analyze the rate and types of malignancies occurring...
4.
Saleeb R, Faragalla H, Yousef G, Stewart R, Streutker C
Pathol Res Pract
. 2015 May;
211(8):584-7.
PMID: 26008778
Background: The increased risk of malignancy in the post-renal transplant population has been well documented. Renal carcinoma is more common in this population, usually arising in native kidneys. Rarely, tumors...
5.
White N, Masui O, Newsted D, Scorilas A, Romaschin A, Bjarnason G, et al.
Br J Cancer
. 2014 Feb;
110(5):1250-9.
PMID: 24496460
Background: Metastatic clear cell renal cell carcinoma (ccRCC) patients have <9% 5-year survival rate, do not respond well to targeted therapy and eventually develop resistance. A better understanding of molecular...
6.
Dorn J, Bayani J, Yousef G, Yang F, Magdolen V, Kiechle M, et al.
Thromb Haemost
. 2013 Jun;
110(3):408-22.
PMID: 23765253
Kallikrein-related peptidases (KLK), which represent a major tissue-associated proteolytic system, stand for a rich source of biomarkers that may allow molecular classification, early diagnosis and prognosis of human malignancies as...
7.
Markou A, Sourvinou I, Vorkas P, Yousef G, Lianidou E
Lung Cancer
. 2013 Jun;
81(3):388-396.
PMID: 23756108
Deregulation of miRNAs expression levels has been detected in many human tumor types, and recent studies have demonstrated the critical roles of miRNAs in cancer pathogenesis. Numerous recent studies have...
8.
Khella H, Bakhet M, Allo G, Jewett M, Girgis A, Latif A, et al.
Carcinogenesis
. 2013 May;
34(10):2231-9.
PMID: 23715501
MicroRNAs (miRNAs) play a crucial role in tumor progression and metastasis. We, and others, recently identified a number of miRNAs that are dysregulated in metastatic renal cell carcinoma compared with...
9.
White N, Khella H, Grigull J, Adzovic S, Youssef Y, Honey R, et al.
Br J Cancer
. 2011 Oct;
105(11):1741-9.
PMID: 22033272
Background: Renal cell carcinoma (RCC) is the most common neoplasm of the adult kidney. Metastatic RCC is difficult to treat. The 5-year survival rate for metastatic RCC is ≤10%. Recently,...
10.
Rotondo F, Sharma S, Scheithauer B, Horvath E, Syro L, Cusimano M, et al.
Neoplasma
. 2010 Sep;
57(6):590-3.
PMID: 20845998
Unlabelled: Vascularization is a prerequisite of tumor growth, invasion and metastasis. In the present work, microvessel density was assessed by quantitating using two different endothelial cell biomarkers, endoglin (CD-105) and...